Jennifer Kim
Stock Analyst at Cantor Fitzgerald
(0)
# 3480
Out of 5,218 analysts
44
Total ratings
38.46%
Success rate
0.40%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Insmed | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
Fortress Biotech | Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
EyePoint Pharmaceuti... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
Belite Bio | Reiterates: Overweight | n/a | n/a | n/a | 3 | Jun 20, 2024 | |
Allakos | Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | 9.52 | 47.06% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.87 | 129.89% | 2 | Aug 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 14 | 3.67 | 281.47% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 | 5.09 | 548.33% | 2 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 5 | 2.83 | 59.01% | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 100 | 1.41 | 6992.2% | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 56 | n/a | n/a | 2 | Mar 17, 2022 |